Pulmonary Resectable Metastases of Osteosarcoma With Apatinib and CHemotherapy
Status:
Recruiting
Trial end date:
2022-09-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate the efficacy and safety of Second-line chemotherapy
combined with Apatinib for the patients with resectable pulmonary metastasis of osteosarcoma.